What does PHARMACIE BEULS do?

PHARMACIE BEULS is a pharmacy in Mouscron. Public Limited, started on 23 November 1987, 1 establishment.

What is the address of PHARMACIE BEULS?

The registered office of PHARMACIE BEULS is located at Dorpstraat(L) 7, 7700 Mouscron.

Is PHARMACIE BEULS still active?

Yes. According to the CBE (31 October 2026) PHARMACIE BEULS is active, legal situation “Normale toestand”, started on 23 November 1987.

Is PHARMACIE BEULS registered on Peppol?

Yes, PHARMACIE BEULS is registered on the Peppol network with ID 0208:0432602380.

What is the enterprise number of PHARMACIE BEULS?

The enterprise number of PHARMACIE BEULS is BE0432602380.

When was PHARMACIE BEULS founded?

PHARMACIE BEULS was founded on 23 November 1987.

Who are the directors of PHARMACIE BEULS?

According to the 2025 annual accounts, the directors of PHARMACIE BEULS are: Guillaume Beuls, Immo & Management Beuls SA.

Is PHARMACIE BEULS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 23 November 1987; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did PHARMACIE BEULS make in 2025?

PHARMACIE BEULS posted a profit after taxes of € 35,617 in financial year 2025.

What is the revenue of PHARMACIE BEULS?

As a small company, PHARMACIE BEULS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 216,282.

How much does an employee at PHARMACIE BEULS earn?

The average wage cost per full-time employee at PHARMACIE BEULS was € 73,500 in 2025: staff costs of € 198,422 for 2.7 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHARMACIE BEULS have?

According to the 2025 annual accounts, PHARMACIE BEULS has 2.7 full-time equivalents (FTE).

PHARMACIE BEULS (Public Limited) - Mouscron

Dossier PHARMACIE BEULS, printed on 31 October 2026 from databakkes.be/en/0432602380/pharmacie-beuls. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PHARMACIE BEULS from Mouscron, company number BE0432602380, closed financial year 2025 with a result of € 35,617 after tax. For that financial year PHARMACIE BEULS recorded a gross margin of € 216,282 and equity of € 115,781. Compared with financial year 2024, the result moved from € 60,885 to € 35,617. The company is profitable. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 12, 2026.

What it is worth Growing

€ 115,781

▲ 1% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 35,617

▼ 42% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 602,478

▲ 1% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 34,000 paid out

95 % of the profit went to the shareholders, mostly to IMMO & MANAGEMENT BEULS (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

2.7

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 198,422

▲ 6% vs 2024

€ 73,500 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 91,598

▼ 6% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 31,004

▲ 3% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 125,709 Gross margin 2022: € 125,709 First fiscal year in the series	€ 209,734 Gross margin 2023: € 209,734 ▲ 67% vs 2022 (€ 125,709) Favourable step	€ 231,604 Gross margin 2024: € 231,604 ▲ 10% vs 2023 (€ 209,734) Favourable step	€ 216,282 Gross margin 2025: € 216,282 ▼ 7% vs 2024 (€ 231,604) Unfavourable step	▼ 7%
Profit after taxes	€ -1,814 Profit after taxes 2022: € -1,814 First fiscal year in the series	€ 37,483 Profit after taxes 2023: € 37,483 ▲ € 39,298 vs 2022 (€ -1,814) Favourable step	€ 60,885 Profit after taxes 2024: € 60,885 ▲ 62% vs 2023 (€ 37,483) Favourable step	€ 35,617 Profit after taxes 2025: € 35,617 ▼ 42% vs 2024 (€ 60,885) Unfavourable step	▼ 42%
Equity	€ 110,796 Equity 2022: € 110,796 First fiscal year in the series	€ 113,280 Equity 2023: € 113,280 ▲ 2% vs 2022 (€ 110,796) Favourable step	€ 114,165 Equity 2024: € 114,165 ▲ 1% vs 2023 (€ 113,280) Favourable step	€ 115,781 Equity 2025: € 115,781 ▲ 1% vs 2024 (€ 114,165) Favourable step	▲ 1%
Total debts	€ 1,008,756 Total debts 2022: € 1,008,756 First fiscal year in the series	€ 1,162,673 Total debts 2023: € 1,162,673 ▲ 15% vs 2022 (€ 1,008,756) Unfavourable step	€ 1,297,364 Total debts 2024: € 1,297,364 ▲ 12% vs 2023 (€ 1,162,673) Unfavourable step	€ 1,331,386 Total debts 2025: € 1,331,386 ▲ 3% vs 2024 (€ 1,297,364) Unfavourable step	▲ 3%
Cash	€ 504,085 Cash 2022: € 504,085 First fiscal year in the series	€ 604,633 Cash 2023: € 604,633 ▲ 20% vs 2022 (€ 504,085) Favourable step	€ 594,670 Cash 2024: € 594,670 ▼ 2% vs 2023 (€ 604,633) Unfavourable step	€ 602,478 Cash 2025: € 602,478 ▲ 1% vs 2024 (€ 594,670) Favourable step	▲ 1%
Retained profit	€ 48,796 Retained profit 2022: € 48,796 First fiscal year in the series	€ 51,280 Retained profit 2023: € 51,280 ▲ 5% vs 2022 (€ 48,796) Favourable step	€ 52,165 Retained profit 2024: € 52,165 ▲ 2% vs 2023 (€ 51,280) Favourable step	€ 53,781 Retained profit 2025: € 53,781 ▲ 3% vs 2024 (€ 52,165) Favourable step	▲ 3%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 35,000 Dividend 2023: € 35,000 Unchanged (€ 0) Unchanged	€ 60,000 Dividend 2024: € 60,000 ▲ 71% vs 2023 (€ 35,000) Unchanged	€ 34,000 Dividend 2025: € 34,000 ▼ 43% vs 2024 (€ 60,000) Unchanged	▼ 43%
Balance sheet total	€ 1,119,552 Balance sheet total 2022: € 1,119,552 First fiscal year in the series	€ 1,275,953 Balance sheet total 2023: € 1,275,953 ▲ 14% vs 2022 (€ 1,119,552) Unchanged	€ 1,411,528 Balance sheet total 2024: € 1,411,528 ▲ 11% vs 2023 (€ 1,275,953) Unchanged	€ 1,447,167 Balance sheet total 2025: € 1,447,167 ▲ 3% vs 2024 (€ 1,411,528) Unchanged	▲ 3%
Employees (FTE)	2.5 Employees (FTE) 2022: 2.5 First fiscal year in the series	2.8 Employees (FTE) 2023: 2.8 ▲ 0.3 vs 2022 (2.5) Unchanged	2.7 Employees (FTE) 2024: 2.7 ▼ 0.1 vs 2023 (2.8) Unchanged	2.7 Employees (FTE) 2025: 2.7 Unchanged (2.7) Unchanged

Key figures of PHARMACIE BEULS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE BEULS?

What happened at PHARMACIE BEULS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2029 Guillaume Beuls stepped down as director. NBB
2029 Immo & Management Beuls SA stepped down as director. NBB
Jun 12, 2026 New annual accounts for financial year 2025: profit of € 35,617 (▼ 42% vs 2024). Source: NBB ↗
2023 Guillaume Beuls became a director. NBB
2023 Immo & Management Beuls SA became a director. NBB
Dec 17, 1987 New establishment in Mouscron. KBO
Nov 23, 1987 Start of the company according to the CBE. KBO

In short

From € 1,814 loss in 2022 to € 35,617 profit in 2025.

Paid € 5,636 in corporate taxes since 2022.

Best year ever: 2024, with € 60,885 profit.

On average € 80,100 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

IMMO & MANAGEMENT BEULS 99.6%

The stake of IMMO & MANAGEMENT BEULS comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

PHARMACIE BEULS

The shares are held by IMMO & MANAGEMENT BEULS (99.6%).

Directors

According to the 2025 annual accounts

Guillaume Beuls

Director

Also active at: PILLPHARM

since 2023 · until 2029

Immo & Management Beuls SA

Managing director · represented by Philippe Beuls

since 2023 · until 2029

Shareholders

IMMO & MANAGEMENT BEULS

99.6%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Dorpstraat(L) 7

7700 Mouscron

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

PILLPHARM same network

€ 29,411 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0432.602.380

VAT number

BE 0432.602.380

Registered office

Dorpstraat(L) 7, 7700 Mouscron

Names & denominations

PHARMACIE BEULS

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

23 November 1987

Peppol

Active · Active since 25 Sept 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMACIE BEULS

Financials

What happened to PHARMACIE BEULS?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions